Stevenson, Wong & Co. advised Kwung’s Holdings Limited (“Kwung’s”, Stock Code: 1925.hk) as its Hong Kong legal advisers on its initial public offering (“IPO”) on the Main Board of The Stock Exchange of Hong Kong Limited.

The IPO comprised an issue of a total of 100 million shares priced at HK$1.28 per share, raising gross proceeds of approximately HK$128 million.

Kwung’s is a prominent original design manufacturer and supplier of home decoration products, comprising candles, home fragrance and home accessories which are sold to customers situated in more than 20 countries and regions, including France, United Kingdom, the Netherlands, Germany, Canada and Australia where candles and home fragrance are widely used in ordinary people’s daily life.

The SW team was led by corporate partners Hank Lo and Cornelia Chu and senior associate Terence Lau, supported by associates Edwin Au and Elly Woo, registered foreign lawyer George Huang, paralegal Collina See and trainee solicitor Jane Yip.

The Sole Sponsor and Sole Global Coordinator was China Industrial Securities International Capital Limited. The Joint Bookrunners were China Industrial Securities International Capital Limited and BOCOM International Securities Limited. The Joint Lead Managers were China Industrial Securities International Capital Limited, BOCOM International Securities Limited, Blackwell Global Securities Limited, Yicko Securities Limited, Lee Go Securities Limited and Sinomax Securities Limited.

Please contact Mr. Hank Lo or Ms. Cornelia Chu for any enquiries or further information about this transaction.

Stevenson, Wong & Co. advised World Super Holdings Limited (Stock Code: 8612) (“World Super”) on its successful listing on GEM of The Stock Exchange of Hong Kong Limited on 12 July 2019. World Super offered a total of 150 million shares priced at $0.55 per share, raising gross proceeds of approximately HK$82.5 million.

World Super and its subsidiaries mainly (i) rent crawler cranes, oscillators, reverse circulation drills and hydromill trench cutters for construction projects in Hong Kong and Macau; (ii) trade crawler cranes, reverse circulation drills, trench cutters, oscillators and/or related spare parts to customers in Hong Kong, Macau and the Philippines; and (iii) provide machinery transportation services and other affiliated services

From left to right: Mr. Alvin Lam, Registered Foreign Lawyer; Ms. Cornelia Chu, Partner; Mr. Albert Sou, Chairman, Executive Director and Chief Executive Officer of World Super and Ms. Collina See, Paralegal.

Our team was led by our partner Cornelia Chu, supported by team members including Alvin Lam (Registered Foreign Lawyer), Tommy Chan (Trainee Solicitor) and Collina See (Paralegal)

Please contact our Ms. Cornelia Chu for any enquiries or further information.

Our senior associate Mr. Gordon Tsang acted as the Joint Company Secretary of Mabpharm Limited – B (stock code: 2181) (“Mabpharm”) in its successful listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) under Chapter 18A of the Hong Kong Main Board Listing Rules.

The shares of Mabpharm were listed on the Stock Exchange on 31 May 2019. The final offer price was HK$1.50 per share and the proceeds amounted to approximately HK$1.068 billion.

Mabpharm’s pipeline contains mAbs to treat cancer and autoimmune diseases, with three biosimilars in Phase III testing: CMAB007, a proposed biosimilar of dermatology and asthma drug Xolair omalizumab from the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY); CMAB009, a proposed biosimilar of cancer drug Erbitux cetuximab from Eli Lilly and Co. (NYSE:LLY); and CMAB008, a proposed biosimilar for autoimmune drug Remicade infliximab from Johnson & Johnson (NYSE:JNJ).

Please contact Mr. Gordon Tsang for further information.

SW acted as the Hong Kong legal advisers to Wai Hung Group Holdings Limited (stock code: 3321) (“Wai Hung Group”) in its successful listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”).

The shares of Wai Hung Group were listed on the Stock Exchange on 23 April 2019. 125 million shares were offered, among which 25 million were public offer shares and 100 million were placing shares. The final offer price was HK$1.4 per share and the proceeds amounted to approximately HK$175 million.

Wai Hung Group is a contractor providing fitting-out services and repair and maintenance services in Macau. Wai Hung Group’s fitting-out services primarily cover refitting works for existing buildings and extend to casinos, retail areas, hotels, restaurants, commercial properties and residential properties.

Please contact our Mr. Hank Lo, Ms. Erica Cheng or Mr. Aaron Xie for any enquiries or further information about this transaction.

SW acted as the Hong Kong legal advisers to Aoyuan Healthy Life Group Company Limited (stock code: 3662) (“Aoyuan Healthy”) in its successful spin-off from China Aoyuan Group Limited (stock code: 3883) (“China Aoyuan”) and the separate listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”).

The shares of Aoyuan Healthy were listed on the Stock Exchange on 18 March 2019. 175 million shares were offered, among which 17.5 million were offered in the Hong Kong public offering and 157.5 million were offered in the international offering. The final offer price was HK$3.66 per share and the proceeds amounted to approximately HK$640.5 million.

China Aoyuan is one of the leading property developers in Guangdong Province in China. Aoyuan Healthy is a renowned property management service and commercial operational service provider in the PRC offering diversified property management services for residential and non-residential properties and a full range of commercial operational services for shopping malls, with a focus on mid to high-end properties and mixed-use property developments.

Please contact our Mr. Hank Lo and Ms. Erica Cheng for any enquiries or further information about this transaction.

SW acted as legal advisers to International Alliance Financial Leasing Co., Ltd. (Stock Code: 1563) (“IA Finance Leasing”) in its successful listing on the Main Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”). IA Finance Leasing offered a total of 495 million shares, which were listed on the Stock Exchange on 15 March 2019.

SW Partner Mr. Rodney Teoh and Mr. Li Luqiang (IA Finance Leasing: Executive Directors)

IA Finance Leasing and its subsidiaries (the “Group”) are a finance leasing company headquartered in Beijing, providing finance leasing and advisory services. The Group targets customers in three targeted industries in the PRC, including the healthcare, aviation and public infrastructure industries. During the track record period, the Group had customers across 17 provinces, two autonomous regions and one municipality in the PRC also one customer incorporated in Singapore and one customer incorporated in the BVI.

Ms. Xu Juan (IA Finance Leasing: Executive Directors) and SW Partner Mr. Rodney Teoh

Mr. Lau Kwok Fai Patrick (IA Finance Leasing: Chief Financial Officer and Company Secretary) and SW Partner Mr. Rodney Teoh

SW Partner Mr. Rodney Teoh, Mr. Michael Tang (Cinda: Executive Director), Mr. Dickson Lau (Cinda: Deputy CEO & Executive Director), Mr. Francis Yeung (Cinda: Managing Director) and SW Partner Mr. Hank Lo

The sole sponsor of the Listing was Cinda International Capital Limited. The joint global coordinators of the Global Offering were Cinda International Capital Limited, ChaoShang Securities Limited and CCB International Capital Limited.

Ms. Florence Wai, Ms. Claire Sit, Mr. Rodney Teoh, Mr. Hank Lo, Mr. Kristopher Wong and Miss Myra Ma

Our team was led by our partners Hank Lo and Rodney Teoh, supported by team members including Kristopher Wong (associate), Florence Wai (associate), Claire Sit (associate) and Myra Ma (trainee solicitor).

Please contact our Mr. Hank Lo or Mr. Rodney Teoh for any enquiries or further information.